Emerging infectious diseases and their impact on emergency medical services
Role of emergency and paramedic
Keywords:
Emerging infectious diseases, zoonotic diseases, vector-borne diseases, One Health, surveillance technologies, emergency medical servicesAbstract
Background: Emerging infectious diseases (EIDs) pose significant threats to global health due to their potential for widespread outbreaks and severe impacts on public health systems. These diseases can emerge from zoonotic sources, environmental changes, or resistance to antibiotics. Approximately 15% of human pathogens are considered to be emerging, reflecting their critical role in public health. Aim: This review aims to evaluate the impact of emerging infectious diseases on emergency medical services, with a focus on the role of zoonotic diseases, vector-borne infections, and the application of advanced surveillance technologies in managing these threats. Methods: A comparative review of literature and data sources, including global surveillance systems and recent outbreak case studies, was conducted to assess the impact of EIDs on emergency medical services. The study also examines the effectiveness of the One Health approach and the role of advanced technologies in disease monitoring. Results: Emerging infectious diseases, including zoonotic and vector-borne infections, have significantly impacted emergency medical services by increasing the demand for urgent care and resource allocation. Advances in surveillance technologies, such as molecular diagnostics and digital platforms, have improved early detection and response capabilities.
Downloads
References
Centers for Disease Control and Prevention (CDC) National Center for Emerging and Zoonotic Infectious Diseases (NCEZID). (2017). NCEZID CD. https://www.cdc.gov/ncezid/index.html.
Petersen, E., Petrosillo, N., & Koopmans, M. (2018). Emerging infections—an increasingly important topic: Review by the Emerging Infections Task Force. Clinical Microbiology and Infection, 24(4), 369–375. https://doi.org/10.1016/j.cmi.2018.01.020 DOI: https://doi.org/10.1016/j.cmi.2017.10.035
Centers for Disease Control and Prevention (CDC). (2018). International Conference on Emerging Infectious Diseases. https://www.cdc.gov/iceid/index.html.
Baylor College of Medicine. (n.d.). Emerging infectious diseases. https://www.bcm.edu/departments/molecular-virology-and-microbiology/emerging-infections-and-biodefense/emerging-infectious-diseases.
Fauci, A. S., & Morens, D. M. (2012). The perpetual challenge of infectious diseases. New England Journal of Medicine, 366(5), 454–461. https://doi.org/10.1056/NEJMra1108298 DOI: https://doi.org/10.1056/NEJMra1108296
Morens, D. M., & Fauci, A. S. (2013). Emerging infectious diseases: Threats to human health and global stability. PLoS Pathogens, 9(7), e1003467. https://doi.org/10.1371/journal.ppat.1003467 DOI: https://doi.org/10.1371/journal.ppat.1003467
Ryu, S., Kim, B. I., Lim, J.-S., & Lee, H. (2017). One health perspectives on emerging public health threats. Journal of Preventive Medicine and Public Health, 50(6), 411–414. https://doi.org/10.3961/jpmph.17.085 DOI: https://doi.org/10.3961/jpmph.17.097
World Health Organization (WHO). (n.d.). Zoonoses. http://www.who.int/zoonoses.
Wolfe, N. D., Dunavan, C. P., & Diamond, J. (2007). Origins of major human infectious diseases. Nature, 447(7142), 279–283. https://doi.org/10.1038/nature05775 DOI: https://doi.org/10.1038/nature05775
Centers for Disease Control and Prevention (CDC) National Center for Emerging and Zoonotic Infectious Diseases (NCEZID). (2018). NCEZID CD. https://www.cdc.gov/ncezid/index.html.
One Health Initiative. (n.d.). One Health Initiative. http://www.onehealthinitiative.com.
Centers for Disease Control and Prevention (CDC). (n.d.). One Health. https://www.cdc.gov/onehealth/index.html.
Rosenberg, R., Lindsey, N. P., Fischer, M., & et al. (2018). Vital signs: Trends in reported vectorborne disease cases—United States and territories, 2004-2016. MMWR Morbidity and Mortality Weekly Report, 67(17), 496–501. https://doi.org/10.15585/mmwr.mm6717e1 DOI: https://doi.org/10.15585/mmwr.mm6717e1
Rathore, M. H., Runyon, J., & Haque, T. U. (2017). Emerging infectious diseases. Advances in Pediatrics, 64, 27–71. https://doi.org/10.1016/j.yapd.2017.05.001 DOI: https://doi.org/10.1016/j.yapd.2017.04.002
Centers for Disease Control and Prevention (CDC). (2018). Yellow fever. https://www.cdc.gov/yellowfever/index.html.
Ramachandran, V. G., Das, S., Roy, P., & et al. (2016). Chikungunya: A reemerging infection spreading during 2010 dengue fever outbreak in National Capital Region of India. Virus Disease, 27(2), 183–186. https://doi.org/10.1007/s13337-016-0322-4 DOI: https://doi.org/10.1007/s13337-016-0314-z
Centers for Disease Control and Prevention (CDC). (n.d.). Dengue. http://www.cdc.gov/dengue/index.html.
Jones, K. E., Patel, N. G., Levy, M. A., & et al. (2008). Global trends in emerging infectious diseases. Nature, 451(7181), 990–993. https://doi.org/10.1038/nature06536 DOI: https://doi.org/10.1038/nature06536
Van Doom, H. R. (2014). Emerging infectious diseases. Medicine, 42(1), 60–63. https://doi.org/10.1016/j.mpmed.2013.11.002 DOI: https://doi.org/10.1016/j.mpmed.2013.10.014
Bunnell, K. L. (2018). 5 emerging infections to watch out for in 2018. Contagion Live-Infectious Diseases Today. https://www.contagionlive.com/publications/contagion/2018.
National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases. (2018). NIAID emerging infectious diseases/pathogens. https://www.niaid.nih.gov/research/emerging-infectious-diseases-pathogens.
MacNair, C. R., Stokes, J. M., Carfrae, L. A., & et al. (2018). Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics. Nature Communications, 9, 458. https://doi.org/10.1038/s41467-017-02771-6 DOI: https://doi.org/10.1038/s41467-018-02875-z
Adams, E., Quinn, M., Tsay, S., & et al. (2018). Candida auris in healthcare facilities, New York, USA, 2013-2017. Emerging Infectious Diseases, 24(10), 1816–1824. https://doi.org/10.3201/eid2410.180401 DOI: https://doi.org/10.3201/eid2410.180649
Sears, D., & Schwartz, B. S. (2017). Candida auris: An emerging multidrug-resistant pathogen. International Journal of Infectious Diseases, 63, 95–98. https://doi.org/10.1016/j.ijid.2017.08.014 DOI: https://doi.org/10.1016/j.ijid.2017.08.017
Centers for Disease Control and Prevention (CDC). (2018). Candida auris. https://www.cdc.gov/fungal/candida-auris.
Yung, C. F., Maiwald, M., Loo, L. H., & et al. (2018). Elizabethkingia anopheles and association with tap water and handwashing, Singapore. Emerging Infectious Diseases, 24(9), 1730–1733. https://doi.org/10.3201/eid2409.171601 DOI: https://doi.org/10.3201/eid2409.171843
Malviya, M., & Bronze, M. S. (2017). Elizabethkingia infections. Medscape. https://emedicine.medscape.com/article/2500046-overview.
Coyle, A. L. (2017). Elizabethkingia anopheles: Exploring the outbreak of disease in the Midwest. Nursing, 47(3), 61–63. https://doi.org/10.1097/01.NURSE.0000513708.07432.05 DOI: https://doi.org/10.1097/01.NURSE.0000512887.67622.84
Castro, C. E. F., Johnson, C., Williams, M., & et al. (2017). Elizabethkingia anopheles: Clinical experience of an academic health system in Southeastern Wisconsin. Open Forum Infectious Diseases, 4(4), 1–4. https://doi.org/10.1093/ofid/ofx210 DOI: https://doi.org/10.1093/ofid/ofx251
Centers for Disease Control and Prevention (CDC). (2015). STARI or Lyme?. https://www.cdc.gov/stari/disease/index.html.
Reynolds, H. H., & Elston, D. M. (2017). What’s eating you? Lone Star Tick (Amblyomma americanum). Cutis, 99(2), 111–114. https://pubmed.ncbi.nlm.nih.gov/28255185
Centers for Disease Control and Prevention (CDC). (2018). Ehrlichiosis. https://www.cdc.gov/ehrlichiosis/index.html.
Centers for Disease Control and Prevention (CDC). (2018). Seasonal flu vs. pandemic flu. https://www.cdc.gov/flu/pandemic-resources/basics/about.html
World Health Organization (WHO). (2018). Influenza fact sheet. http://www.who.int/en/news-room/fact-sheets/detail/influenza-(avian-and-other-zoonotic).
Centers for Disease Control and Prevention (CDC). (2018). H7N2 questions & answers. https://www.cdc.gov/flu/other/flu-in-cats/h7n2-cat-faq.html.
Centers for Disease Control and Prevention (CDC). (2018). Newly reported gene, mcr-1, threatens last-resort antibiotics. https://www.cdc.gov/drugresistance/solutions-initiative/stories/gene-reported=mcr.html.
Centers for Disease Control and Prevention (CDC). (2018). Tracking the mcr gene. https://www.cdc.gov/drugresistance/biggest-threats/tracking/mcr.html.
Al-Tawfiq, J. A., Laxminarayan, R., & Mendelson, M. (2017). How should we respond to the emergence of plasmid-mediated colistin resistance in humans and animals? International Journal of Infectious Diseases, 54, 77–84. https://doi.org/10.1016/j.ijid.2016.10.003 DOI: https://doi.org/10.1016/j.ijid.2016.11.415
Khyatti, M., Trimbitas, R.-D., Zouheir, Y., & et al. (2014). Infectious diseases in North Africa and North African immigrants to Europe. European Journal of Public Health, 24(Suppl 1), 47–56. https://doi.org/10.1093/eurpub/ckt188 DOI: https://doi.org/10.1093/eurpub/cku109
McArthur D. B. (2019). Emerging Infectious Diseases. The Nursing clinics of North America, 54(2), 297–311. https://doi.org/10.1016/j.cnur.2019.02.006 DOI: https://doi.org/10.1016/j.cnur.2019.02.006
Published
How to Cite
Issue
Section
Copyright (c) 2019 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
